000			02308 a2200733 4500
005			20250516121514.0
264		0	_c20130613
008			201306s 0 0 eng d
022			_a1873-2623
024	7		_a10.1016/j.transproceed.2012.09.098 _2doi
040			_aNLM _beng _cNLM
100	1		_aGiakoustidis, D
245	0	0	_aPrevalence and clinical impact of cytomegalovirus infection and disease in renal transplantation: ten years of experience in a single center. _h[electronic resource]
260			_bTransplantation proceedings _cNov 2012
300			_a2715-7 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Urea Nitrogen
650	0	4	_aCreatinine _xblood
650	0	4	_aCytomegalovirus _xgenetics
650	0	4	_aCytomegalovirus Infections _xdiagnosis
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGanciclovir _xadministration & dosage
650	0	4	_aGraft Survival
650	0	4	_aGreece _xepidemiology
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aIncidence
650	0	4	_aKidney Transplantation _xadverse effects
650	0	4	_aLinear Models
650	0	4	_aLiving Donors
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aPrevalence
650	0	4	_aRetrospective Studies
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aValganciclovir
650	0	4	_aViral Load
700	1		_aAntoniadis, A
700	1		_aFouzas, I
700	1		_aSklavos, A
700	1		_aGiakoustidis, A
700	1		_aOuzounidis, N
700	1		_aGakis, D
700	1		_aKoubanagiti, K
700	1		_aMyserlis, G
700	1		_aTsitlakidis, A
700	1		_aGerogiannis, I
700	1		_aPapagiannis, A
700	1		_aChristoforou, P
700	1		_aDeligiannidis, T
700	1		_aSolonaki, F
700	1		_aImvrios, G
700	1		_aPapanikolaou, V
773	0		_tTransplantation proceedings _gvol. 44 _gno. 9 _gp. 2715-7
856	4	0	_uhttps://doi.org/10.1016/j.transproceed.2012.09.098 _zAvailable from publisher's website
999			_c22258830 _d22258830